Seth Lederman
2023
In 2023, Seth Lederman earned a total compensation of $2.1M as Chief Executive Officer at Tonix Pharmaceuticals Holding, a 55% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,375,065 |
|---|---|
| Salary | $675,000 |
| Total | $2,050,065 |
Lederman received $1.4M in option awards, accounting for 67% of the total pay in 2023.
Lederman also received $675K in salary.
Rankings
In 2023, Seth Lederman's compensation ranked 511th out of 3,006 executives tracked by ExecPay. In other words, Lederman earned more than 83.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 511 out of 3,006 | 83rd |
Division Manufacturing | 293 out of 1,650 | 82nd |
Major group Chemicals And Allied Products | 203 out of 918 | 78th |
Industry group Drugs | 200 out of 881 | 77th |
Industry Pharmaceutical Preparations | 126 out of 637 | 80th |
Source: SEC filing on April 15, 2024.
Lederman's colleagues
We found three more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2023.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019